References
- SiegelRL, MillerKD, JemalA. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi:10.3322/caac.2144229313949
- KohlerBA, WardE, McCarthyBJ, et al. Annual report to the nation on the status of cancer, 1975–2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst. 2011;103(9):714–736. doi:10.1093/jnci/djr07721454908
- StillerCA, BielackSS, JundtG, Steliarova-FoucherE. Bone tumours in European children and adolescents, 1978–1997. Report from the automated childhood cancer information system project. Eur J Cancer. 2006;42(13):2124–2135. doi:10.1016/j.ejca.2006.05.01516919776
- LiC, BalluzLS, OkoroCA, et al. Surveillance of certain health behaviors and conditions among states and selected local areas — behavioral risk factor surveillance system, United States, 2009. MMWR Surveill Summ. 2011;60(9):1–250.
- YinM, YangM, ChuS, et al. Quality analysis of different specification grades of Astragalus membranaceus var. mongholicus (Huangqi) from Hunyuan, Shanxi. J AOAC Int. 2019;102(3):734–740. doi:10.5740/jaoacint.18-030831027520
- KrizovaL, DadakovaK, KasparovskaJ, KasparovskyT. Isoflavones. Molecules. 2019;24(6):1076. doi:10.3390/molecules24061076
- ChenJ, ZhaoX, LiX, WuY. Calycosin induces apoptosis by the regulation of ERbeta/miR-17 signaling pathway in human colorectal cancer cells. Food Funct. 2015;6(9):3091–3097. doi:10.1039/C5FO00374A26215320
- KongL, LiX, WangH, HeG, TangA. Calycosin inhibits nasopharyngeal carcinoma cells by influencing EWSAT1 expression to regulate the TRAF6-related pathways. Biomed Pharmacother. 2011;60:342–348. doi:10.1016/j.biopha.2018.06.143
- QiuR, MaG, LiX, et al. Clinical case report of patients with osteosarcoma and anticancer benefit of calycosin against human osteosarcoma cells. J Cell Biochem. 2019;120(6):10697–10706. doi:10.1002/jcb.v120.630652346
- GuoT, LiuZL, ZhaoQ, ZhaoZM, LiuCH. A combination of astragaloside I, levistilide A and calycosin exerts anti-liver fibrosis effects in vitro and in vivo. Acta Pharmacol Sin. 2018;39(9):1483–1492. doi:10.1038/aps.2017.17529849130
- DahlingerD, DuechtingS, NueckenD, SydowK, FuhrU, FrechenS. Development and validation of an in vitro, seven-in-one human cytochrome P450 assay for evaluation of both direct and time-dependent inhibition. J Pharmacol Toxicol Methods. 2016;77:66–75. doi:10.1016/j.vascn.2015.10.00326528794
- ZhangD, WuGD, ZhangYD, XuJP, ZhenHT, LiMH. Effects of digeda-4 decoction on the CYP450 activities in rats using a cocktail method by HPLC. Biomed Res Int. 2018;2018:1415082. doi:10.1155/2018/141508230426002
- ChengC, QianJ, WangZ, et al. Influences of corydalis decumbens on the activities of CYP450 enzymes in rats with a cocktail approach. Biomed Res Int. 2019;2019:9614781. doi:10.1155/2019/961478130800683
- MaX, ZhangT, WeiY, TuP, ChenY, ItoY. Preparative isolation and purification of calycosin from Astragalus membranaceus Bge. var. mongholicus (Bge.) Hsiao by high-speed counter-current chromatography. J Chromatogr A. 2002;962(1–2):243–247. doi:10.1016/S0021-9673(02)00535-612198969
- RonisMJ. Effects of soy containing diet and isoflavones on cytochrome P450 enzyme expression and activity. Drug Metab Rev. 2016;48(3):331–341. doi:10.1080/03602532.2016.120656227440109
- Kopecna-ZapletalovaM, KrasulovaK, AnzenbacherP, HodekP, AnzenbacherovaE. Interaction of isoflavonoids with human liver microsomal cytochromes P450: inhibition of CYP enzyme activities. Xenobiotica. 2017;47(4):324–331.27312150
- PirmohamedM, JamesS, MeakinS, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15–19. doi:10.1136/bmj.329.7456.1515231615
- LeeJY, JunSA, HongSS, AhnYC, LeeDS, SonCG. Systematic review of adverse effects from herbal drugs reported in randomized controlled trials. Phytother Res. 2016;30(9):1412–1419. doi:10.1002/ptr.v30.927196988
- VideauO, PitarqueS, TroncaleS, et al. Can a cocktail designed for phenotyping pharmacokinetics and metabolism enzymes in human be used efficiently in rat? Xenobiotica. 2012;42(4):349–354. doi:10.3109/00498254.2011.62545322321050